Company Filing History:
Years Active: 2013
Title: The Innovative Contributions of Aly Hussain in Retinal Regeneration
Introduction
Aly Hussain is a notable inventor based in London, GB. He has made significant strides in the field of retinal regeneration, contributing to advancements that could improve the quality of life for individuals with retinal degradation. His innovative approach focuses on enhancing retinal function through a unique method that targets Bruch's membrane.
Latest Patents
Aly Hussain holds a patent for a method of retinal regeneration. This method improves retinal function by reversing the degradation of the transport properties of Bruch's membrane. The technique involves the irradiation of the retinal pigmented epithelium through the cornea of the eye using a laser pulse or a sequence of laser pulses. The pulse duration ranges from 10 picoseconds to 20 microseconds, with a wavelength between 500 nm and 900 nm. This method applies a radiant exposure that alters the retinal pigmented epithelium cells, triggering cellular responses that enhance the hydraulic conductivity of Bruch's membrane without causing irreversible damage to adjacent retinal structures.
Career Highlights
Aly Hussain is currently associated with Ellex R&D Pty Ltd, where he continues to develop and refine his innovative techniques. His work is pivotal in the ongoing research and development of retinal therapies, showcasing his commitment to advancing medical science.
Collaborations
Aly has collaborated with notable professionals in his field, including Malcolm Plunkett and John Marshall. These collaborations have further enriched his research and contributed to the success of his innovative projects.
Conclusion
Aly Hussain's contributions to retinal regeneration exemplify the impact of innovation in medical technology. His patented method represents a significant advancement in the treatment of retinal degradation, highlighting the importance of continued research and collaboration in this vital area of healthcare.